Dermavant appoint Todd Zavodnick as CEO
November 15, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Roivant subsidiary Dermavant has appointed experienced pharma exec Todd Zavodnick as the company’s new CEO. The Rutger’s University graduate will …
Rising to the challenge of delivering therapeutic discovery for mental disorders
November 15, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NIHRm, Oxford, R&D, feature, investment, mental health
Professor Matthew Hotopf, Director of NIHR Maudsley Biomedical Research Centre, and Professor John R Geddes, Director of NIHR Oxford Health …
Kymriah to be made available in UK for paediatric leukaemia patients via Cancer Drugs Fund
November 15, 2018Sales and Marketing CAR-T, Cancer, Cancer Drugs Fund, Kymriah, NHS, NICE, leukaemia, pharma
NICE has announced its recommendation that Novartis’ CAR-T cell therapy Kymriah (tisagenlecleucel) be made available in the treatment of relapsed …
MSD’s Keytruda improvess overall survival in Phase 3 oesophageal cancer
November 15, 2018Research and Development Cancer, MSD, PD-L1, keytruda, pharma
MSD has announced new Phase 3 data on its anti-PD-1 therapy Keytruda (pembrolizumab) as a second-line treatment for advanced or …
Phamaceutical trade lobby responds to Brexit deal
November 15, 2018Business Services, Medical Communications, Research and Development ABPI, brexit, negotiations, pharma, politics
The Association of the British Pharmaceutical Industry (ABPI) has responded to Theresa May’s Brexit deal, after the government announced a …
Pfizer defeated in Britain’s highest court over Lyrica patent
November 15, 2018Business Services, Medical Communications Legislation, Lyrica, Pfizer, court, pharma
American pharma firm Pfizer have lost in the final round of a protracted court battle over the patent on epilepsy …
Novartis denies potential split with Sandoz
November 15, 2018Business Services, Manufacturing and Production Business, M&A, MA, Novartis, Sandoz, acquisition, mergers
Swiss newspaper Tages-Anzeiger has reported that Novartis is preparing for a split with long-term partner Sandoz. The two companies merged …
Company tackling antimicrobial resistance appoint former Bayer VP as new managing director
November 14, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
British company Matoke Pharma have appointed former Bayer VP, Alan Westwood, as the firm’s new managing director, a role in …
3 in 4 UK diabetes patients suffer from mental health issues, says report
November 14, 2018Medical Communications, Research and Development UK, World Diabetes Day, diabetes, pharma
To mark this year’s World Diabetes Day on 14 November, a new report has shed more light on the psychological …
German health minister Jens Spahn calls for faster adoption of biosimilars
November 14, 2018Research and Development AbbVie, Germany, biosimilars, jens Spahn
Germany’s health minister Jens Spahn has called for faster uptake of biosimilars in an effort to cut the cost of …
Ebola outbreak in Congo may last another 6 months, WHO officials say
November 14, 2018Research and Development Congo, Ebola, WHO, health, infectious diseases
The outbreak of Ebola in the Democratic Republic of Congo (DRC) is expected to last until mid-2019, a World Health …
WHO report reveals antibiotic use by country
November 14, 2018Research and Development
Britain uses more than twice as many antibiotics as the Netherlands, according to a new report published by the World …
Samsung BioLogics delisted over accounting violations
November 14, 2018Research and Development Business, Samsung, Samsung BioLogics, accounting, south korea
South Korean firm Samsung BioLogics has been delisted from the South Korean stock exchange. The decision has come after the …
Novartis’ Entresto tops enalapril in stabilised heart failure patients
November 13, 2018Manufacturing and Production, Research and Development Entresto, Novartis, cardiovascular, enalapril, heart failure, pharma
Novartis has declared new findings for Entresto (sacubitril/valsartan) at the American Heart Association’s (AHA) scientific sessions, showing that the drug proved …
Gilead appoint Pfizer and AbbVie veteran as VP of governmental affairs
November 13, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
American antiviral drug specialist Gilead have appointed Pfizer and AbbVie veteran Michael Boyd as VP of government affairs and policy …
Cases of measles nearly quadruple since last year in UK
November 13, 2018Manufacturing and Production MMR, Public Health England, UK, health, measles
Public Health England is urging the public to ensure that they have received two doses of the MMR vaccine after …
Azacitidine and nivolumab combo proves successful in phase II trial
November 13, 2018Manufacturing and Production Cancer, leukaemia, opdivo, pharma, texas
A combination of chemotherapy drug azacitidine and nivolumab (Bristol-Myers Squibb’s Opdivo) has proven effective in treating patients with relapsed or …
AstraZeneca sells off paediatric lung infection drug to Sobi for $1.5bn
November 13, 2018Manufacturing and Production, Sales and Marketing AstraZeneca, Synagis, espiratory syncytial virus, pharma, sobi
AstraZeneca has jettisoned another non-essential asset with the sale of Synagis (palivizumab), a preventative treatment for infections relating to respiratory …
Samsung Biologics shares fall by 20% after Korean investigation
November 13, 2018Manufacturing and Production Shares, accounting, pharma, smasung biologics, stockmarket
Shares in Korean firm Samsung BioLogics plummeted this week, falling by as much as 20% on Monday, after the South …
MSD’s Keytruda chalks up FDA approval in liver cancer
November 12, 2018Sales and Marketing Cancer, FDA, US, hepatocellular carcinoma, keytruda, pharma
MSD’s blockbuster immunotherapy Keytruda has secured another FDA approval, this time for the treatment of hepatocellular carcinoma (HCC) in patients …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
